BioGaia AB (publ) (STO:BIOG.B)
Sweden · Delayed Price · Currency is SEK 122.30
+0.20 (0.16%)
Oct 15, 2026, 2:57 PM CET
BioGaia AB Ratios and Metrics
Market cap in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 12,372 | 10,743 | 11,320 | 10,219 | 8,439 | 10,462 | |
Market Cap Growth | 15.16% | -5.09% | 10.77% | 21.10% | -19.33% | -3.54% |
Enterprise Value | 11,926 | 10,015 | 10,205 | 8,767 | 7,037 | 8,946 |
Last Close Price | 122.10 | 102.95 | 101.41 | 86.80 | 69.75 | 84.10 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 35.60 | 32.28 | 32.22 | 27.97 | 22.58 | 53.30 |
Forward PE | 28.56 | 27.23 | 29.29 | 26.42 | 29.95 | 50.89 |
PS Ratio | 7.81 | 6.99 | 7.96 | 7.88 | 7.64 | 13.33 |
PB Ratio | 11.22 | 8.18 | 6.57 | 5.03 | 4.28 | 5.57 |
P/TBV Ratio | 13.06 | 9.21 | 7.31 | 5.62 | 4.81 | 6.23 |
P/FCF Ratio | 41.22 | 35.45 | 31.49 | 27.08 | 28.03 | 48.55 |
P/OCF Ratio | 39.24 | 35.04 | 30.33 | 23.99 | 26.46 | 47.15 |
PEG Ratio | - | 1.16 | 1.16 | 1.16 | 1.16 | 1.16 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 7.53 | 6.51 | 7.17 | 6.76 | 6.37 | 11.39 |
EV/EBITDA Ratio | 25.75 | 21.36 | 21.39 | 19.25 | 20.18 | 34.41 |
EV/EBIT Ratio | 27.19 | 22.16 | 22.16 | 19.88 | 21.04 | 36.26 |
EV/FCF Ratio | 39.73 | 33.05 | 28.39 | 23.23 | 23.38 | 41.51 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | - | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 |
Debt / EBITDA Ratio | - | 0.05 | 0.06 | 0.08 | 0.04 | 0.04 |
Debt / FCF Ratio | - | 0.08 | 0.08 | 0.09 | 0.05 | 0.05 |
Net Debt / Equity Ratio | -0.40 | -0.59 | -0.69 | -0.74 | -0.75 | -0.79 |
Net Debt / EBITDA Ratio | -0.98 | -1.66 | -2.50 | -3.31 | -4.22 | -5.67 |
Net Debt / FCF Ratio | -1.49 | -2.57 | -3.32 | -4.00 | -4.89 | -6.84 |
Asset Turnover | 1.14 | 0.85 | 0.65 | 0.57 | 0.51 | 0.39 |
Inventory Turnover | - | 2.56 | 2.35 | 2.14 | 2.46 | 2.31 |
Quick Ratio | 2.11 | 5.21 | 7.02 | 8.60 | 9.93 | 12.99 |
Current Ratio | 4.44 | 6.12 | 7.81 | 9.58 | 10.89 | 13.80 |
Return on Equity (ROE) | 30.79% | 21.91% | 18.72% | 18.25% | 19.42% | 10.83% |
Return on Assets (ROA) | 19.77% | 15.56% | 13.18% | 12.12% | 9.63% | 7.63% |
Return on Invested Capital (ROIC) | 57.70% | 67.02% | 68.78% | 67.28% | 61.90% | 54.48% |
Return on Capital Employed (ROCE) | 38.90% | 32.30% | 25.20% | 20.60% | 16.30% | 12.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.81% | 3.10% | 3.10% | 3.57% | 4.43% | 1.88% |
FCF Yield | 2.43% | 2.82% | 3.17% | 3.69% | 3.57% | 2.06% |
Dividend Yield | 3.27% | 1.54% | 1.74% | 1.88% | 1.74% | 0.70% |
Payout Ratio | 116.64% | 59.28% | 54.60% | 40.08% | 19.68% | 35.09% |
Buyback Yield / Dilution | - | -0.09% | -0.09% | - | - | -13.11% |
Total Shareholder Return | 3.28% | 1.46% | 1.65% | 1.88% | 1.74% | -12.41% |